JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB44392

Anti-Plasma Kallikrein 1B 抗体

Anti-Plasma Kallikrein 1B antibody

5

(6 Reviews)

|

(4 Publications)

Rabbit Polyclonal Plasma Kallikrein 1B antibody. Suitable for ELISA, WB, IHC-P and reacts with Mouse, Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human KLKB1.

別名を表示する

KLK3, KLKB1, Plasma kallikrein, Fletcher factor, Kininogenin, Plasma prekallikrein, PKK

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Mouse, Human

アプリケーション

WB, ELISA, IHC-P

applications

免疫原

Synthetic Peptide within Human KLKB1. The exact immunogen used to generate this antibody is proprietary information.

P03952

特異性

This antibody is specific for Plasma Kallikrein 1B (amino end of the catalytic domain).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>1/1000 when using colorimetric substrates such as BCIP/NBT, and 1/5000 for chemiluminescent substrates. EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. Dilution optimised using Chromogenic detection.</p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Mouse": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>1/1000 when using colorimetric substrates such as BCIP/NBT, and 1/5000 for chemiluminescent substrates. EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. Dilution optimised using Chromogenic detection.</p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
Preservative: 0.05% Sodium azide Constituents: 50% Glycerol (glycerin, glycerine)
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Plasma Kallikrein 1B also known as PKK or KLKB1 is a serine protease enzyme with an approximate mass of 88 kDa. It is important for the blood coagulation process. This protein is mainly expressed in the liver and circulates in the blood as the inactive precursor prekallikrein. Through cleavage prekallikrein converts into its active form plasma kallikrein. Plasma kallikrein exhibits various proteolytic activities influencing multiple substrates involved in hemostatic and inflammatory responses.
Biological function summary

Plasma Kallikrein 1B plays significant roles in the kinin-kallikrein system. Within this system it cleaves high-molecular-weight kininogen to release bradykinin a potent vasodilator. This enzyme is not part of a larger protein complex but operates independently to modulate various physiological responses. Plasma kallikrein's activity influences processes like pain vasodilation and inflammation making it important in homeostasis and acute-phase responses.

Pathways

Plasma Kallikrein 1B participates actively in the kallikrein-kinin and the contact activation pathways. In the kallikrein-kinin system it works alongside high-molecular-weight kininogen and factor XII which plays an important role in the intrinsic pathway of coagulation. Plasma kallikrein's enzymatic activities lead to the production of bradykinin and other peptides impacting blood pressure and inflammatory processes.

Plasma Kallikrein 1B associates strongly with hereditary angioedema and diabetic retinopathy. In hereditary angioedema its dysregulation leads to excessive bradykinin production causing episodes of swelling. In diabetic retinopathy elevated plasma kallikrein activity can exacerbate vascular complications. Plasma kallikrein's disorderly activities also connect it to other proteins like C1 inhibitor in these pathological conditions highlighting its importance in clinical studies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Participates in the surface-dependent activation of blood coagulation. Activates, in a reciprocal reaction, coagulation factor XII/F12 after binding to negatively charged surfaces. Releases bradykinin from HMW kininogen and may also play a role in the renin-angiotensin system by converting prorenin into renin.
See full target information KLKB1

文献 (4)

Recent publications for all applications. Explore the full list and refine your search

Zoological research 45:1001-1012 PubMed39147715

2024

Bat-derived oligopeptide LE6 inhibits the contact-kinin pathway and harbors anti-thromboinflammation and stroke potential.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Na Cha,Juan Yang,Jin-Ai Gao,Xin Lu,Xiao-Long Chang,Rebecca Caroline Thuku,Qi Liu,Qiu-Min Lu,Dong-Sheng Li,Ren Lai,Ming-Qian Fang

Frontiers in pharmacology 14:1287487 PubMed38178859

2024

Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation.

Applications

Unspecified application

Species

Unspecified reactive species

Allen C Clermont,Nivetha Murugesan,Hannah J Edwards,Daniel K Lee,Natasha P Bayliss,Edward J Duckworth,Stephen J Pethen,Sally L Hampton,David Gailani,Edward P Feener

Science advances 7: PubMed33523981

2021

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Rasmus Pihl,Rasmus K Jensen,Emil C Poulsen,Lisbeth Jensen,Annette G Hansen,Ida B Thøgersen,József Dobó,Péter Gál,Gregers R Andersen,Jan J Enghild,Steffen Thiel

Brain : a journal of neurology 143:1780-1797 PubMed32428221

2020

Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenwei Yu,Min Shi,Tessandra Stewart,Pierre-Olivier Fernagut,Yang Huang,Chen Tian,Benjamin Dehay,Anzari Atik,Dishun Yang,Francesca De Giorgi,François Ichas,Marie-Hélène Canron,Roberto Ceravolo,Daniela Frosini,Han-Joon Kim,Tao Feng,Wassilios G Meissner,Jing Zhang
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com